메뉴 건너뛰기
Journal of Nutrition, Health and Aging
Volumn 14, Issue 7, 2010, Pages 531-536
Eolving attitudes to Alzheimer's disease among the general public and caregivers in Europe: Findings from the IMPACT survey
Author keywords

ageing; Alzheimer's disease; attitudes; caregivers; general public; survey
Indexed keywords

ALZHEIMER DISEASE; ARTICLE; ATTITUDE TO MENTAL ILLNESS; AWARENESS; CAREGIVER; CLINICAL EFFECTIVENESS; EUROPE; HEALTH SURVEY; HUMAN; POPULATION; PRIORITY JOURNAL; QUESTIONNAIRE; AGING; ATTITUDE TO HEALTH; COMPARATIVE STUDY; FEAR; GOVERNMENT; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HEALTH CARE POLICY; INFORMATION PROCESSING; PSYCHOLOGICAL ASPECT; STANDARD; TREATMENT OUTCOME;
EID: 77957967552     PISSN: 12797707     EISSN: 17604788     Source Type: Journal    
DOI: 10.1007/s12603-010-0264-x     Document Type: Article
Times cited : (18)
References (14)
  • 2
    • 77957933333 scopus 로고    scopus 로고
    • Assessing attitudes and behaviours surrounding Alzheimer's disease in Europe: Key findings of the Important Perspectives on Alzheimer's Care and Treatment (IMPACT) survey
    • 1:STN:280:DC%2BC3cjpvV2lug%3D%3D 10.1007/s12603-010-0263-y 20818466
    • R.W. Jones J. Mackell K. Berthet S. Knox 2010 Assessing attitudes and behaviours surrounding Alzheimer's disease in Europe: key findings of the Important Perspectives on Alzheimer's Care and Treatment (IMPACT) survey J Nutr Health Aging 14 7 525 530 1:STN:280:DC%2BC3cjpvV2lug%3D%3D 10.1007/s12603-010- 0263-y 20818466
    • (2010) J Nutr Health Aging , vol.14 , Issue.7 , pp. 525-530
    • Jones, R.W.1    MacKell, J.2    Berthet, K.3    Knox, S.4
  • 3
    • 0344034779 scopus 로고    scopus 로고
    • Diagnosing cognitive impairment and dementia in primary health care - A more active approach is needed
    • DOI 10.1093/ageing/afg097
    • M. Lopponen I. Raiha R. Isoaho T. Vahlberg S.L. Kivela 2003 Diagnosing cognitive impairment and dementia in primary health care - a more active approach is needed Age Ageing 32 6 606 612 10.1093/ageing/afg097 14600001 (Pubitemid 37461568)
    • (2003) Age and Ageing , vol.32 , Issue.6 , pp. 606-612
    • Lopponen, M.1    Raiha, I.2    Isoaho, R.3    Vahlberg, T.4    Kivela, S.-L.5
  • 4
    • 33947660033 scopus 로고    scopus 로고
    • Diagnosis of dementia in primary care: A representative survey of family physicians and neuropsychiatrists in Germany
    • DOI 10.1159/000099470
    • G. Stoppe S. Haak A. Knoblauch L. Maeck 2007 Diagnosis of dementia in primary care: a representative survey of family physicians and neuropsychiatrists in Germany Dement Geriatr Cogn Disord 23 4 207 214 10.1159/000099470 17290103 (Pubitemid 46496805)
    • (2007) Dementia and Geriatric Cognitive Disorders , vol.23 , Issue.4 , pp. 207-214
    • Stoppe, G.1    Haak, S.2    Knoblauch, A.3    Maeck, L.4
  • 5
    • 0034706426 scopus 로고    scopus 로고
    • The detection of dementia in the primary care setting
    • 1:STN:280:DC%2BD3crgt1Wktg%3D%3D 10.1001/archinte.160.19.2964 11041904
    • V.G. Valcour K.H. Masaki J.D. Curb P.L. Blanchette 2000 The detection of dementia in the primary care setting Arch Intern Med 160 19 2964 2968 1:STN:280:DC%2BD3crgt1Wktg%3D%3D 10.1001/archinte.160.19.2964 11041904
    • (2000) Arch Intern Med , vol.160 , Issue.19 , pp. 2964-2968
    • Valcour, V.G.1    Masaki, K.H.2    Curb, J.D.3    Blanchette, P.L.4
  • 6
    • 0035964226 scopus 로고    scopus 로고
    • A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease
    • 1:CAS:528:DC%2BD3MXmslymtrg%3D 11524468
    • H. Feldman S. Gauthier J. Hecker B. Vellas P. Subbiah E. Whalen 2001 A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease Neurology 57 4 613 620 1:CAS:528:DC%2BD3MXmslymtrg%3D 11524468
    • (2001) Neurology , vol.57 , Issue.4 , pp. 613-620
    • Feldman, H.1    Gauthier, S.2    Hecker, J.3    Vellas, B.4    Subbiah, P.5    Whalen, E.6
  • 7
    • 3242775357 scopus 로고    scopus 로고
    • The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease
    • 1:CAS:528:DC%2BD2cXlsV2jt78%3D 15277611
    • C. Holmes D. Wilkinson C. Dean, et al. 2004 The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease Neurology 63 2 214 219 1:CAS:528:DC%2BD2cXlsV2jt78%3D 15277611
    • (2004) Neurology , vol.63 , Issue.2 , pp. 214-219
    • Holmes, C.1    Wilkinson, D.2    Dean, C.3
  • 8
    • 0035859851 scopus 로고    scopus 로고
    • A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients [published erratum appears in Neurology. 2001;57:1942]
    • 1:CAS:528:DC%2BD3MXms1Srurs%3D 11502917
    • R.C. Mohs R.S. Doody J.C. Morris, et al. 2001 A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients [published erratum appears in Neurology. 2001;57:1942] Neurology 57 3 481 488 1:CAS:528:DC%2BD3MXms1Srurs%3D 11502917
    • (2001) Neurology , vol.57 , Issue.3 , pp. 481-488
    • Mohs, R.C.1    Doody, R.S.2    Morris, J.C.3
  • 10
    • 0031883716 scopus 로고    scopus 로고
    • A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease
    • Donepezil Study Group. 1:CAS:528:DyaK1cXotVKjsA%3D%3D 9443470
    • S.L. Rogers M.R. Farlow R.S. Doody R. Mohs L.T. Friedhoff Donepezil Study Group 1998 A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease Neurology 50 1 136 145 1:CAS:528: DyaK1cXotVKjsA%3D%3D 9443470
    • (1998) Neurology , vol.50 , Issue.1 , pp. 136-145
    • Rogers, S.L.1    Farlow, M.R.2    Doody, R.S.3    Mohs, R.4    Friedhoff, L.T.5
  • 11
    • 85052636661 scopus 로고    scopus 로고
    • Efficacy and safety of rivastigmine in patients with Alzheimer's disease: International randomised controlled trial [published erratum appears in: BMJ. 2001;322:1456]
    • 1:CAS:528:DyaK1MXitVShtr4%3D 10066203
    • M. Rosler R. Anand A. Cicin-Sain, et al. 1999 Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial [published erratum appears in: BMJ. 2001;322:1456] BMJ 318 7184 633 638 1:CAS:528:DyaK1MXitVShtr4%3D 10066203
    • (1999) BMJ , vol.318 , Issue.7184 , pp. 633-638
    • Rosler, M.1    Anand, R.2    Cicin-Sain, A.3
  • 12
    • 0034720864 scopus 로고    scopus 로고
    • A 5-month, randomized, placebo-controlled trial of galantamine in AD
    • 1:CAS:528:DC%2BD3cXltFSmsL8%3D 10881251
    • P.N. Tariot P.R. Solomon J.C. Morris, et al. 2000 A 5-month, randomized, placebo-controlled trial of galantamine in AD Neurology 54 12 2269 2276 1:CAS:528:DC%2BD3cXltFSmsL8%3D 10881251
    • (2000) Neurology , vol.54 , Issue.12 , pp. 2269-2276
    • Tariot, P.N.1    Solomon, P.R.2    Morris, J.C.3
  • 13
    • 72549099594 scopus 로고    scopus 로고
    • Donepezil treatment in severe Alzheimer's disease: A pooled analysis of three clinical trials
    • 1:CAS:528:DC%2BD1MXht1Kqu77F 19735164
    • B. Winblad S.E. Black A. Homma, et al. 2009 Donepezil treatment in severe Alzheimer's disease: a pooled analysis of three clinical trials Curr Med Res Opin 25 2577 2587 1:CAS:528:DC%2BD1MXht1Kqu77F 19735164
    • (2009) Curr Med Res Opin , vol.25 , pp. 2577-2587
    • Winblad, B.1    Black, S.E.2    Homma, A.3
  • 14
    • 70350673942 scopus 로고    scopus 로고
    • Safety and tolerability of donepezil, rivastigmine and galantamine for patients with Alzheimer's disease: Systematic review of the 'real-world' evidence
    • 1:CAS:528:DC%2BD1MXhsFygu7%2FF 10.1159/000255578 19893314
    • I.A. Lockhart S.A. Mitchell S. Kelly 2009 Safety and tolerability of donepezil, rivastigmine and galantamine for patients with Alzheimer's disease: systematic review of the 'real-world' evidence Dement Geriatr Cogn Disord 28 5 389 403 1:CAS:528:DC%2BD1MXhsFygu7%2FF 10.1159/000255578 19893314
    • (2009) Dement Geriatr Cogn Disord , vol.28 , Issue.5 , pp. 389-403
    • Lockhart, I.A.1    Mitchell, S.A.2    Kelly, S.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.